This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université´ D'aix-Marseille. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021
Title: Stéphane Betzi: Innovator in Xanthine Derivatives
Introduction
Stéphane Betzi is a notable inventor based in Marseilles, France. He has made significant contributions to the field of chemistry, particularly in the development of xanthine derivatives. His work focuses on creating compounds that serve as inhibitors of bromodomains of BET proteins.
Latest Patents
Stéphane Betzi holds a patent for "Xanthine derivatives and uses thereof as inhibitors of bromodomains of BET proteins." This invention relates to a compound characterized by a specific formula, where R is a (C-C)alkyl group, R" is preferably H, Ar is a (C-C)arylene radical, X is either C(=O) or SO, and R' is selected from a group that includes possibly substituted (C-C)alkyl, heteroaryl, (C-C)aryl, and (hetero)cycloalkyl groups, or a pharmaceutically acceptable salt and/or tautomeric form thereof, or its racemates, diastereomers, or enantiomers. He has 1 patent to his name.
Career Highlights
Throughout his career, Stéphane has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Université d'Aix-Marseille. His research has contributed to advancements in medicinal chemistry and drug development.
Collaborations
Stéphane has collaborated with notable colleagues, including Sébastien Combes and Yves Collette. These partnerships have enhanced his research and innovation efforts in the field.
Conclusion
Stéphane Betzi is a distinguished inventor whose work on xanthine derivatives has the potential to impact therapeutic applications significantly. His contributions to research and development continue to inspire advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile